THE USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN AS A VEHICLE FOR INTRAVENOUS ADMINISTRATION OF DEXAMETHASONE IN DOGS

被引:33
作者
DIETZEL, K
ESTES, KS
BREWSTER, ME
BODOR, NS
DERENDORF, H
机构
[1] UNIV FLORIDA,COLL PHARM,DEPT PHARMACEUT,BOX J-494,GAINESVILLE,FL 32610
[2] UNIV FLORIDA,COLL PHARM,CTR DRUG DESIGN & DELIVERY,GAINESVILLE,FL 32610
关键词
Amorphous cyclodextrin; Bioavailability; Dexamethasone; Dexamethasone phosphate; Dog; HPLC; Inclusion complex; Pharmacokinetics;
D O I
10.1016/0378-5173(90)90113-I
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dexamethasone (Dex) was administered to 6 mongrel dogs in a dose of 5 mg/kg as the sodium salt of its phosphate ester or as an inclusion complex in 2-hydroxypropyl-β-cyclodextrin (HPCD). Blood and urine were collected and analyzed for dexamethasone by HPLC. The area under the plasma concentration time curve (AUC) of dexamethasone during the first hour was significantly greater after the administration of the Dex-HPCD complex compared to the phosphate ester prodrug (1.63 ± 0.13 vs 1.04 ± 0.10 μg h ml-1). In addition, the renal clearance (CLren) was significantly higher after administration of the HPCD form (0.91 ± 0.20 vs 0.52 ± 0.20 ml min-1 kg-1). There was no difference between treatments for other pharmacokinetic parameters of dexamethasone. Hence, intravenous injection of dexamethasone in HPCD allows direct administration of this poorly soluble steroid without any prodrug conversion. The higher plasma levels during the first hour after administration may be advantageous for the treament of emergency situations. © 1990.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 18 条
[1]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .31. SOLUBILIZATION AND STABILIZATION OF AN ESTRADIOL CHEMICAL DELIVERY SYSTEM BY MODIFIED BETA-CYCLODEXTRINS [J].
BREWSTER, ME ;
ESTES, KS ;
LOFTSSON, T ;
PERCHALSKI, R ;
DERENDORF, H ;
MULLERSMAN, G ;
BODOR, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (11) :981-985
[2]   AN INTRAVENOUS TOXICITY STUDY OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN, A USEFUL DRUG SOLUBILIZER, IN RATS AND MONKEYS [J].
BREWSTER, ME ;
ESTES, KS ;
BODOR, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 59 (03) :231-243
[3]   SEVERE HYPERVITAMINOSIS A IN SIBLINGS - EVIDENCE OF VARIABLE TOLERANCE TO RETINOL INTAKE [J].
CARPENTER, TO ;
PETTIFOR, JM ;
RUSSELL, RM ;
PITHA, J ;
MOBARHAN, S ;
OSSIP, MS ;
WAINER, S ;
ANAST, CS .
JOURNAL OF PEDIATRICS, 1987, 111 (04) :507-512
[4]   HPLC DETERMINATION OF GLUCOCORTICOID ALCOHOLS, THEIR PHOSPHATES AND HYDROCORTISONE IN AQUEOUS-SOLUTIONS AND BIOLOGICAL-FLUIDS [J].
DERENDORF, H ;
ROHDEWALD, P ;
HOCHHAUS, G ;
MOLLMANN, H .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1986, 4 (02) :197-206
[5]  
FRANK DW, 1976, AM J PATHOL, V83, P367
[6]  
HIASA Y, 1981, Journal of Nara Medical Association, V32, P316
[7]   INTERACTION OF PHARMACEUTICALS WITH SCHARDINGER DEXTRINS .2. INTERACTION WITH SELECTED COMPOUNDS [J].
LACH, JL ;
COHEN, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (02) :137-+
[8]   COMPARATIVE PHARMACOKINETICS OF METHYLPREDNISOLONE PHOSPHATE AND HEMISUCCINATE IN HIGH-DOSES [J].
MOLLMANN, H ;
ROHDEWALD, P ;
BARTH, J ;
MOLLMANN, C ;
VERHO, M ;
DERENDORF, H .
PHARMACEUTICAL RESEARCH, 1988, 5 (08) :509-513
[9]   SOLUBILIZATION OF DRUGS BY MODIFIED BETA-CYCLODEXTRINS [J].
MULLER, BW ;
BRAUNS, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 26 (1-2) :77-88
[10]   HYDROXYPROPYL-BETA-CYCLODEXTRIN - PREPARATION AND CHARACTERIZATION - EFFECTS ON SOLUBILITY OF DRUGS [J].
PITHA, J ;
MILECKI, J ;
FALES, H ;
PANNELL, L ;
UEKAMA, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 29 (01) :73-82